Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-02-22 @ 9:36 AM
Study NCT ID:
NCT02706392
Status:
TERMINATED
Last Update Posted:
2022-08-31
First Post:
2016-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hematopoietic and Lymphoid Cell Neoplasm | View |
| None | Malignant Solid Neoplasm | View |
| None | Metastatic Lung Non-Small Cell Carcinoma | View |
| None | Metastatic Triple-Negative Breast Carcinoma | View |
| None | Recurrent Acute Lymphoblastic Leukemia | View |
| None | Recurrent Mantle Cell Lymphoma | View |
| None | Refractory Chronic Lymphocytic Leukemia | View |
| None | Stage III Lung Non-Small Cell Cancer AJCC v7 | View |
| None | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | View |
| None | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | View |
| None | Stage IV Breast Cancer AJCC v6 and v7 | View |
| None | Stage IV Lung Non-Small Cell Cancer AJCC v7 | View |
| None | Unresectable Lung Non-Small Cell Carcinoma | View |
Keywords: